Biological properties of new derivatives of daunorubicin

In Vivo

Volumn 21, Issue 2, 2007, Pages 413-416

  Wasowska Lukawska, Malgorzata ^a   Wietrzyk, Joanna ^b   Opolski, Adam ^b   Oszczapowicz, Janusz ^c   Oszczapowicz, Irena ^a  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antharacyclines; Antiproliferative activity; Chiral substituent; Daunorubicin; Drug resistance barrier

Indexed keywords

ALPHA METHYLBENZYLAMINE; DAUNORUBICIN DERIVATIVE;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; MULTIDRUG RESISTANCE; STRUCTURE ACTIVITY RELATION;

EID: 34047217648     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wasowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S and Oszczapowicz: J: Influence of the structure of new anthracycline antibiotics on their biological properties. Anticancer Res 25: 2043-2048, 2005.
2. Wasowska M, Wietrzyk J, Opolski A, Oszczapowicz J and Oszczapowicz I: Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. Anticancer Res 26: 2009-2012, 2006.
3. Somogyi A, Bochner F and Foster D: Inside the isomers: the tale of chiral switches. Aust Prescr 27: 47-49, 2004.
4. Agranat I, Caner H and Cadwell J: Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1: 753-768, 2002.
5. Oszczapowicz I, Wasowska M, Oszczapowicz J, Owoc A, Dominiczak E, Wietrzyk J and Opolski A: Polish patent appl no. P 376208, 2005.
6. Skehan P, Storeng R, Skudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesh H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
7. Marcinkowska E, Kutner A and Radzikowski C: Cell differentiating and antiproliferative activity of side-chain modified analogues of 1, 25-dihydroxyvitamin D3. J Steroid Biochem Molec Biol 67: 71-78, 1998.
8. Harker WG, Slade WS, Meltzer PS and Trent JM: Multidrug resistance in mitoxantrone HL leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res 49: 4542-4549, 1989.
9. Geran R I, Greenberg NH, MacDonald MM, Schimacher AM and Abbott BJ: Cancer Chemotherapy Reports 3: 59-61, 1972.